Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Berz

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Annals of Thoracic Surgery|April 21, 2019
Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural MesotheliomaFernando Espinoza-Mercado, Jerald D Borgella, David Berz, et al.
Journal of Cellular Physiology|September 24, 2009
Heterogeneity of non-cycling and cycling synchronized murine hematopoietic stem/progenitor cellsGerald A Colvin, David Berz, Liansheng Liu, et al.
Future Oncology (London, England)|January 16, 2025
Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumorsKevin Harrington, Shigehisa Kitano, Valentina Gambardella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2025
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With <i>HER2</i> Alterations: A Phase Ia Dose-Escalation StudyJohn V Heymach, Frans Opdam, Minal Barve, et al.
Frontiers in Oncology|June 6, 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung CancerHumera Khurshid, Thomas Dipetrillo, Thomas Ng, et al.
Oncotarget|December 15, 2018
Anticancer activity of 2'-hydroxyflavanone towards lung cancerSanjay Awasthi, Sharad S Singhal, Jyotsana Singhal, et al.
Cancers|June 6, 2020
Rlip Depletion Suppresses Growth of Breast CancerChhanda Bose, Sushma Yadav, Sharad S Singhal, et al.
Experimental Hematology|January 19, 2010
Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcriptionJason M Aliotta, Mandy Pereira, Kevin W Johnson, et al.
Experimental Hematology|August 26, 2011
Marrow cell genetic phenotype change induced by human lung cancer cellsMichael Del Tatto, Thomas Ng, Jason M Aliotta, et al.
American Journal of Clinical Oncology|May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II studyHoward Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Annals of Thoracic Surgery|April 21, 2019
Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural MesotheliomaFernando Espinoza-Mercado, Jerald D Borgella, David Berz, et al.
Journal of Cellular Physiology|September 24, 2009
Heterogeneity of non-cycling and cycling synchronized murine hematopoietic stem/progenitor cellsGerald A Colvin, David Berz, Liansheng Liu, et al.
Future Oncology (London, England)|January 16, 2025
Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumorsKevin Harrington, Shigehisa Kitano, Valentina Gambardella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2025
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With <i>HER2</i> Alterations: A Phase Ia Dose-Escalation StudyJohn V Heymach, Frans Opdam, Minal Barve, et al.
Frontiers in Oncology|June 6, 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung CancerHumera Khurshid, Thomas Dipetrillo, Thomas Ng, et al.
Oncotarget|December 15, 2018
Anticancer activity of 2'-hydroxyflavanone towards lung cancerSanjay Awasthi, Sharad S Singhal, Jyotsana Singhal, et al.
Cancers|June 6, 2020
Rlip Depletion Suppresses Growth of Breast CancerChhanda Bose, Sushma Yadav, Sharad S Singhal, et al.
Experimental Hematology|January 19, 2010
Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcriptionJason M Aliotta, Mandy Pereira, Kevin W Johnson, et al.
Experimental Hematology|August 26, 2011
Marrow cell genetic phenotype change induced by human lung cancer cellsMichael Del Tatto, Thomas Ng, Jason M Aliotta, et al.
American Journal of Clinical Oncology|May 8, 2013
Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II studyHoward Safran, Kevin P Charpentier, Andreas Kaubisch, et al.
Pageof 4